등록자료 카탈로그 · HER2+ 유방암

208개 · 저장 분류: ADC 55 · 항체 등 117 · CGT 36 · 선정 등록 36건 대조 2026-11-02

자동 수집 등록자료가 포함된 탐색용 목록입니다. 약물별 상세 해설 검토가 끝난 목록과 구분하며 이 목록 화면은 검색 색인 대상에서 제외합니다. 등록 단계·시험 수는 효능 또는 경쟁력의 판정이 아닙니다.

인기최근 업데이트큐레이션임상 많은갱신 필요최신Phase 3FDA승인프로그램 208개
AntibodyLimited Data등록자료 · 상세 해설 미완료RochePreclinical

trastuzumab (Herceptin, Pertuzumab Plus Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#항체#Preclinical#면역항체#Roche
저장된 시험 연결 30상태 ACTIVE
AntibodyLimited Data등록자료 · 상세 해설 미완료RochePreclinical

trastuzumab (Herceptin, Pyrotinib Plus Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#항체#Preclinical#면역항체#Roche
저장된 시험 연결 30상태 ACTIVE
ADCLimited Data등록자료 · 상세 해설 미완료RochePhase 2

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 and Pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#BreastNeoplasms+2
저장된 시험 연결 30상태 RECRUITING
ADCCurated Core등록자료 · 상세 해설 미완료Merck Sharp & Dohme LLCPhase 3

Patritumab Deruxtecan (Patritumab Deruxtecan)

Breast Neoplasms; Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#바이오정보모아추천#항체약물접합체+3
저장된 시험 연결 29상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Zhiyong YuPhase 2

Inetetamab (Inetetamab)

Metastatic Breast Cancer · HER2

#HER2#항체#Phase2#면역항체#MetastaticBreastCancer+1
저장된 시험 연결 26상태 ACTIVE
ADCLimited Data등록자료 · 상세 해설 미완료GileadPhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Sacituzumab Govitecan / Trastuzumab Deruxtecan)

Triple Negative Breast Neoplasms; Neoplasm Metastasis · Triple Negative Breast Neoplasms

#TripleNegativeBreastNeoplasms#ADC#Phase2#항체약물접합체#NeoplasmMetastasis+1
저장된 시험 연결 24상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료Byondis B.V.Phase 3

trastuzumab (Herceptin, vic-, (vic-)trastuzumab duocarmazine)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#항체약물접합체#Byondis
저장된 시험 연결 23상태 ACTIVE
AntibodyLimited Data등록자료 · 상세 해설 미완료RegeneronPhase 2

Cemiplimab plus REGN3767 (Cemiplimab plus REGN3767)

Breast Neoplasms; Breast Cancer · HER2

#HER2#항체#Phase2#면역항체#BreastNeoplasms+2
저장된 시험 연결 23상태 RECRUITING
CGTLimited Data등록자료 · 상세 해설 미완료Beijing BiotechPhase 2

Dual-target CAR-NK cells (Dual-target CAR-NK cells)

Breast Cancer (Advanced/Metastatic); HER2-positive Breast Cancer · Malignant Glioma

#MalignantGlioma#세포·유전자 치료#Phase2#세포유전치료#CAR-T+4
저장된 시험 연결 23상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료RochePhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, HER2,trastuzumab deruxtecan± pertuzumab)

Salivary Gland Carcinoma; Precision Therapy · HER2

#HER2#ADC#Phase2#항체약물접합체#SalivaryGlandCarcinoma+2
저장된 시험 연결 23상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료RemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Tislelizumab)

Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma · HER2

#HER2#ADC#Phase2#항체약물접합체#Her2OverexpressingHigh-RiskNon-M+1
저장된 시험 연결 17상태 ACTIVE
ADCLimited Data등록자료 · 상세 해설 미완료RemeGenApproved

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Tislelizumab)

Breast Cancer; Neoadjuvant Therapy · Breast Cancer

#BreastCancer#ADC#Approved#항체약물접합체#NeoadjuvantTherapy+1
저장된 시험 연결 17상태 ACTIVE
ADCLimited Data등록자료 · 상세 해설 미완료Daiichi SankyoPhase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, T-Dxd + Pertuzumab)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#HER2+BreastCancer+1
저장된 시험 연결 17상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Kite, A Gilead CompanyPhase 1

Utomilumab (Utomilumab)

Relapsed/Refractory Large B-cell Lymphoma · HER2

#HER2#항체#Phase1#면역항체#Relapsed+2
저장된 시험 연결 17상태 ACTIVE
AntibodyLimited Data등록자료 · 상세 해설 미완료ALX Oncology Inc.Phase 2

ALX148 (Evorpacept, Evorpacept (ALX148))

Breast Cancer, Metastatic · Breast Cancer, Metastatic

#BreastCancerMetastatic#항체#Phase2#면역항체#BreastCancer+2
저장된 시험 연결 15상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료RochePhase 1

trastuzumab (Herceptin, Hyaluronidase-zzxf/Pertuzumab/Trastuzumab)

Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm · Advanced Breast Carcinoma

#AdvancedBreastCarcinoma#항체#Phase1#면역항체#AdvancedMalignantSolidNeoplasm+1
저장된 시험 연결 15상태 DISCONTINUED
CGTLimited Data등록자료 · 상세 해설 미완료Shenzhen Geno-Immune Medical In…Phase 2

4SCAR T cells (4SCAR T cells)

Breast Cancer · Autoimmune Diseases

#AutoimmuneDiseases#세포·유전자 치료#Phase2#세포유전치료#CAR-T+2
저장된 시험 연결 14상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Hoffmann-La RochePhase 2

Selicrelumab (Selicrelumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#항체#Phase2#면역항체#Hoffmann-La
저장된 시험 연결 13상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료AstraZenecaPhase 1

durvalumab (Imfinzi, Administration of ceralasertib and durvalumab)

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer · Adv Solid Malig - H&N SCC, ATM Pro / Def

#AdvSolidMalig-HNSCCATMProDef#항체#Phase1#면역항체#AdvSolidMalig-HNSCC+3
저장된 시험 연결 12상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료AstraZenecaPhase 2

durvalumab (Imfinzi, Datopotamab deruxtecan + Durvalumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#BreastNeoplasms+2
저장된 시험 연결 11상태 RECRUITING

3 / 11 pages

← PreviousNext →